Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 601–700 of 999
Pharmacology for the Geriatric Surgical Patient
Then, J., & Tisherman, S. A. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.09.013 · Cited by 3
Rate control in atrial fibrillation, insight into the RACE II study
Groenveld, H. F., Crijns, H. J. G. M., Tijssen, J. G. P., Alings, M., Hillege, H. L., Tuininga, Y. S., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2013) · Netherlands Heart Journal · doi:10.1007/s12471-013-0391-1 · Cited by 4
“However, the incidence of heart failure was similar between the two groups [37].”
BackgroundResultInfluentialSelf-citationAtrial fibrillation: A moving target
Eckstein, J., Conen, D., & Kuehne, M. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14078 · Cited by 4
MANAGEMENT OPTIONS FOR ATRIAL FIBRILLATION
Bobo, T. (2010) · Cited by 3
Sarkar, S., & Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.791 · Cited by 3
Tracy, C. M., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., Ellenbogen, A. L., Lowe, J. E., Page, R. L., Wann, L. S., Curtis, A. B., & January, C. T. (2011) · Cited by 3
Кохан, Е. В., Kiyakbaev, G. K., & Kobalava, Z. D. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2019-25-4-389-406 · Cited by 3
Issa, Z. F., Miller, J. M., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-1274-8.00015-4 · Cited by 7
Contemporary management of persistent atrial fibrillation
Gupta, D., & Ding, W. Y. (2021) · Heart · doi:10.1136/heartjnl-2020-317422 · Cited by 3
McCartney, D., Lomas, O., & Cahill, T. J. (2014) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738014541425 · Cited by 3
Which therapy for which condition?
Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00021-1 · Cited by 3
Mischke, K., Zarse, M., Knackstedt, C., & SCHAUERTE, P. N. (2011) · Cardiology Research and Practice · doi:10.4061/2011/162984 · Cited by 3
Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation
Dahya, V., & Taigen, T. L. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.04.004 · Cited by 3
Rate Control for Permanent Atrial Fibrillation
PASSMAN, R. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.039 · Cited by 3
Is High Heart Rate Always Harmful to Heart Failure Patients?
Okada, S., Iwahana, T., & Kobayashi, Y. (2020) · Circulation Journal · doi:10.1253/circj.cj-20-0198 · Cited by 3
Mechanisms and Management of Arrhythmias in Cancer Patients
Agarwal, M. A., Sridharan, A., Pham, H. N., Garg, L., Patel, B. D., Abdel-Qadir, H. M., Moudgil, R., Sadler, D. B., Rickard, J., & Fradley, M. G. (2025) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-025-01072-8 · Cited by 2
“The optimal heart rate target in cancer AF patients is unclear due to exclusion of this population in pivotal studies such as the RACE II trial [141].”
Atrial fibrillation with slow-ventricular response (AF-SVR): A literature review
Choi, J., Kong, D., Katić, L., Torelli, V. A., Karpenos, J., Marković, N., & Mehta, D. (2025) · The Journal of Medicine Access · doi:10.1177/27550834251342890 · Cited by 2
“13”
Dizdarevic, A. M., Šramko, M., Mangner, N., Merkely, B. P., Zima, E., Nikolaos, N., Scherr, D., Knotzer, H., Köglberger, P., Nouvaki, Z., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf129 · Cited by 2
Cardiology and cardiac surgery – a symbiosis of successful treatment of heart failure
Uskach, T. M., Amanatova, V. A., Фаресовна, А. Д., Валерьевич, С. О., Эмвярович, И. Т., & Tereshchenko, S. N. (2025) · Terapevticheskii arkhiv · doi:10.26442/00403660.2025.09.203375 · Cited by 2
Korneev, A. B. (2026) · Journal of Arrhythmology · doi:10.35336/va-1523 · Cited by 2
Pedretti, R. F. E., Craenenbroeck, E. M. V., Vrints, C., Ambrosetti, M., Kurpas, D., Vassiliou, V. S., Bäck, M., Moholdt, T. T., Sionís, A., Wilhelm, M., et al. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag236 · Cited by 7
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001472 · Cited by 3
Aktuelle Therapie tachykarder Herzrhythmusstörungen
Tebbenjohanns, J., & Rühmkorf, K. (2013) · Der Internist · doi:10.1007/s00108-013-3325-5 · Cited by 2
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
Olshansky, B., & Sullivan (2010) · Core evidence · doi:10.2147/ce.s7015 · Cited by 2
Tratamiento antiarrítmico farmacológico en fase crónica de la fibrilación auricular
Martí‐Almor, J., Bazán, V., Vallès, E., & Benito, B. (2013) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(13)70055-4 · Cited by 3
Atrial Arrhythmias and Heart Failure
Kusmirek, S. (2017) · Springer eBooks · doi:10.1007/978-1-4471-4219-5_14 · Cited by 2
2018 Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation
Lim, W., Choi, E., Joung, B., & Choi, K. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.133 · Cited by 2
“RACE 연구의 연구 대상자들은 대부분 좌심실 부전이 없는 환자들이며 느슨한 심박수 조절군의 78%가 안정시 맥박수 가 100회/분으로 양 군 간의 심박수 차이가 10회분에 불과하 였다[34].”
Tarzimanova, A. I., & Doshchitsin, V. L. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2962 · Cited by 2
Arrhythmia-Induced Cardiomyopathy: Mechanisms and Risk Assessment to Guide Management and Follow-Up
Chong, L., Gopinathannair, R., Ahmad, A., Mar, P. L., & Olshansky, B. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00699-7 · Cited by 2
New Progress of Positive Inotropic Drugs in the Treatment of Heart Failure
熊, 珂. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.127948 · Cited by 3
β-Blockers, Central Sympathetic Agents, and Direct Vasodilators
Katsurada, K., & Kario, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00024-4 · Cited by 2
Frick, W. H., Zhang, Z., Rogers, L., Rojulpote, C., & Lin, C.-J. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102669 · Cited by 2
Rate Versus Rhythm Control for Atrial Fibrillation with Heart Failure
Saksena, S. V., & Slee, A. E. (2024) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2024.09.002 · Cited by 2
Impact of heart rate on eGFR decline in ischemic stroke patients
Lee, J.-D., Kuo, Y., Lee, C.-P., Huang, Y.-C., Lee, M., & Lee, T.-H. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae387 · Cited by 2
“In the RACE II trial, the degree of heart rate control did not significantly impact major cardiovascular events in patients with atrial fibrillation [36 ].”
Gupta, S., Steinacher, E., Lutnik, M., Cacioppo, F., Schnaubelt, S., Koller, L., Domanovits, H., Spiel, A. O., Herkner, H., Schwameis, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-93855-z · Cited by 2
“24–28 , the observed rates appear quite high.”
Kodani, E., Yamashita, T., Inoue, H., Atarashi, H., Okumura, K., Origasa, H., & J‐RHYTHM Registry Investigators (2025) · Clinical Cardiology · doi:10.1002/clc.70122 · Cited by 2
Jamaluddin, J., Liong, S. F., Beh, H. C., Chong, K., Choong, J. W., Zakaria, A. F., & Kadir, N. A. N. A. (2025) · Malaysian Family Physician · doi:10.51866/cpg.872 · Cited by 2
Sanders, P., Ariyaratnam, J., Puvrez, A., Middeldorp, M. E., Nicholls, S. J., Thomas, G., Ganesan, A. N., Paul, V., Thomas, S. P., Abhayaratna, W. P., et al. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.07.018 · Cited by 2
2025 Thai guideline for the diagnosis and management of atrial fibrillation
Ngarmukos, T., Methavigul, K., Rungpradubvong, V., Apiyasawat, S., Wongcharoen, W., Pumprueg, S., Boonyapisit, W., Suwanagool, A., Chantrarat, T., Makarawate, P., et al. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0028 · Cited by 3
“However, the study had limitations, as the heart rate differences between the two groups were about 10 bpm [70].”
Pharmacological Treatment of Atrial Fibrillation
Oh, S. (2011) · Cited by 2
Sánchez, S. D., González, A. M., Rodríguez, Á. C., & Obaya, J. C. (2019) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2018.11.002 · Cited by 2
Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation.
Rillig, A., Lin, T., Ouyang, F. O., Kück, K., & Tilz, R. R. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.861 · Cited by 2
Wang, W., Li, F., Huang, H., Wu, X., Tian, W., & Yu, T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1084300 · Cited by 2
“Meanwhile, studies have shown that it is appropriate to keep the resting ventricular rate of AF patients with heart failure at around 90 bpm field (2, 9).”
BackgroundMethodNölker, G., Gutleben, K., Asbach, S., Ritscher, G., Marschang, H., Sinha, A. M. S., Boileau, P., Benser, M. E., Hallier, B., Hummer, A., et al. (2011) · EP Europace · doi:10.1093/europace/eur243 · Cited by 2
Rubenstein, J., & Roth, J. A. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9238-2 · Cited by 2
“A recent randomized trial did not find any difference in endpoints to patients with strict rate control (resting heart rate \80 beats per minute and heart rates during moderate exercise \110 beats per minute) vs. those with relaxed rate control (resting heart rate \110 beats per minute) [ 32 ].”
BackgroundThe Editor's Roundtable: Medical Management of Atrial Fibrillation
Friedewald, V. E., Kowal, R. C., Olshansky, B., Yancy, C. W., & Roberts, W. C. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.11.013 · Cited by 2
Dori, G. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.11.012 · Cited by 2
“Palpitations during AF are sensed by approximately 25% of patients [14].”
BackgroundContemporary therapy of atrial fibrillation
Yang, X. S., Sun, J. P., & Yu, C. (2012) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2012.23018 · Cited by 3
“The potential benefits of strict (resting heart rate < 80 bpm, heart rate < 110 bpm during moderate exercise) versus lenient (resting heart rate < 110 bpm) rate control were reported in the RACE II trial of 614 patients with permanent AF [27].”
BackgroundRecent Advances in the Pharmacological Management of Atrial Fibrillation
Gooden, J. Y., Powell, B. D., Akogyeram, C. O., & Melduni, R. M. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31828d4532 · Cited by 2
Medikamentöse Frequenzkontrolle bei Vorhofflimmern
Näbauer, M. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0299-5 · Cited by 2
Toufan, M., Akbarzadeh, F., & Arabmaleki, M. (2013) · Archives of Cardiovascular Imaging · doi:10.5812/acvi.13842 · Cited by 2
“Maintenance of sinus rhythm could be effective in improving the quality of life and heart performance in patients with congestive heart failure (CHF), and also, could decrease the risk of thromboembolism and the side effects of long term anti coagulation therapy (9, 10).”
BackgroundChicos, A. B., & Knight, B. P. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.05.003 · Cited by 2
Does Better Rate Control Improve Quality of Life?
Dorian, P., & Ha, A. C. T. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.052 · Cited by 2
Knapp, E., & Watson, K. (2011) · Europe PMC (PubMed Central) · Cited by 5
Doğan, V., Başaran, Ö., Beton, O., Tekinalp, M., Bolat, İ., Kalaycıoğlu, E., Aykan, A. Ç., Taşar, O., Şafak, Ö., Kalçık, M., et al. (2016) · Coronary Artery Disease · doi:10.1097/mca.0000000000000389 · Cited by 2
Грайфер, И. В., Reshetko, O. V., & Фурман, Н. В. (2011) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2011-7-2-177-184 · Cited by 2
Atienza, F., & Moya‐Mitjans, À. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30013-9 · Cited by 3
STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
Канорский, С. Г., & Kovalenko, Y. S. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-7-171-177 · Cited by 3
Atrial Fibrillation: Thinking Beyond Thromboembolism
Reddy, Y. N. V., & Borlaug, B. A. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1683 · Cited by 2
Therapeutisches Management des nichtvalvulären Vorhofflimmerns
Gunawardene, M., Hartmann, J., Jularic, M., Eickholt, C., Geßler, N., & Willems, S. (2020) · Herz · doi:10.1007/s00059-020-04960-w · Cited by 2
Schleberger, R., Rillig, A., Kirchhof, P. F., Metzner, A., & Reißmann, B. (2021) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00749-4 · Cited by 4
Lau, Y. C., & Lip, G. Y. H. (2014) · Medicine · doi:10.1016/j.mpmed.2014.07.013 · Cited by 3
O’Connor, M., Kolb, C., Klein, N., Rauwolf, T., Küster, S., Kääb, S., Tilz, R. R., Bänsch, D., İnce, H., Belke, R., et al. (2022) · Technology and Health Care · doi:10.3233/thc-220432 · Cited by 3
Evaluation of Safety and Efficacy of Intravenous Digoxin Loading Doses Based on Ideal Body Weight
Clark, J. L., Jacobs, J. A., Watanabe, A. H., Catino, A. B., & Dechand, J. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280221146530 · Cited by 2
Perioperative cardiac risk reduction in non cardiac surgery
Thilagar, B., Mueller, M. R., & Ganesh, R. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08474-4 · Cited by 3
Barcía, J. A. P., Raposeiras‐Roubín, S., Fernández, D. G., García, A. G., Otero, C. I., Bermúdez, I. G., Íñiguez, A., & Abu‐Assi, E. (2024) · Clinical Cardiology · doi:10.1002/clc.24257 · Cited by 3
Fast atrial fibrillation and caecal volvulus – a case report and evidence based management
Liu, A., & Nicol, E. D. (2011) · BMJ Case Reports · doi:10.1136/bcr.10.2011.4982 · Cited by 1
Postoperatives Vorhofflimmern: Bedeutung, Prophylaxe und Therapie
Knaut, M., Sindt, M., & Madej, T. (2017) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-017-0140-7 · Cited by 4
“Beim randomisierten Vergleich einer „strikten“ (Ziel: <80/min) und einer „lockeren“ (Ziel <110/min) Frequenzkontrolle zeigte sich kein relevanter Unterschied, sodass bei asymptomatischen Patienten initial eine Zielfrequenz <110/min empfohlen werden kann [37].”
MethodThe Timing and Role of Atrial Fibrillation Ablation in Heart Failure Patients
Batul, S. A., & Gopinathannair, R. (2018) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-018-0587-4 · Cited by 3
The ABCs of atrial fibrillation
Hussein, M. T. E., & Kilfoil, L. (2020) · The Nurse Practitioner · doi:10.1097/01.npr.0000681780.47800.a3 · Cited by 2
To the Editor—Atrial Fibrillation Guidelines
Li, H. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.02.025 · Cited by 2
Impact of Catheter Ablation on Quality of Life in Patients with Atrial Fibrillation
Andréa, B. R., & Hindricks, G. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02214.x · Cited by 2
Smit, M. D., & Gelder, I. C. V. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0119-z · Cited by 2
Slowing down the heart rate in permanent atrial fibrillation
Ehrlich, J. R., & Ovsyshcher, E. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht476 · Cited by 2
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
Advances in the management of atrial fibrillation
Li, A. C., & Behr, E. R. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-544 · Cited by 1
Comparison of heart rate and symptoms in two different methods of digoxin prescription
Mousavi, M., & Akbarian, M. (2021) · Journal of Cardiology & Current Research · doi:10.15406/jccr.2021.14.00527 · Cited by 1
Vinereanu, D., WOJDYLA, D. M., Alexander, J. H., Lópes, R. D., Al‐Khatib, S. M., Gersh, B. J., Bahit, M. C., Hohnloser, S. H., Flaker, G. C., Rosenquist, M., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.006 · Cited by 1
van der Velden, R. M. J., Pluymaekers, N. A. H. A., Dudink, E. A. M. P., LUERMANS, J. G. L. M., Meeder, J. G., Heesen, W. F., Lenderink, T., Widdershoven, J. W. M. G., Bucx, J. J. J., Rienstra, M., et al. (2023) · Clinical Cardiology · doi:10.1002/clc.24161 · Cited by 1
“6,9,10 Whether a delayed cardioversion strategy also impacts the quality of rate control during recurrences of AF beyond the presenting episode, is currently unknown.”
BackgroundSelf-citationAtrial Fibrillation: Rate Versus Rhythm Control
Vargas, C., Bhatnagar, M., Ahmed, H. S., Flynn, M. G., & Alexander, T. (2023) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1564 · Cited by 1
Hybrid Endo-Epicardial Therapies for Advanced Atrial Fibrillation
Wong, C. X. J., Buch, E. F., Beygui, R. E., & Lee, R. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030679 · Cited by 1
“Historically, the conventional wisdom was that rate control was equivalent to rhythm restoration in terms of cumulative mortality [39,40].”
BackgroundKomaki, T., Mohri, N., Ideishi, A., Tashiro, K., Koyanagi, N., Miura, S., & Ogawa, M. (2024) · Cardiology Research · doi:10.14740/cr1692 · Cited by 1
“…a comparison between lenient versus strict rate control II) study, Van Gelder et al compared major cardiovascular events in patients with AF treated by a lenient (resting HR 110 bpm) or strict rate-control strategy (resting HR 80 bpm and HR during moderate exercise 110 bpm) [18].”
Atrial Fibrillation and Stroke Prevention
Atasi, M. M., Dankar, R., Francis, J., & Refaat, M. M. (2024) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1006629 · Cited by 1
Maidman, S. D., Aizer, A., Jankelson, L., Holmes, D., Park, D. S., Bernstein, S., Knotts, R. J., Kushnir, A., Chinitz, L. A., & Barbhaiya, C. R. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01965-x · Cited by 2
“In particular, when comparing patients who were rate controlled with resting heart rate 110 bpm, meeting RACE II rate control criteria, there were no differences in the frequency of LVEF recovery in our study [6].”
Liu, Y., Liu, J. H., & Wang, D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1447907 · Cited by 1
Bridging the Gaps in Atrial Fibrillation Management in the Emergency Department
Wang, B. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12010020 · Cited by 2
Challenges and Opportunities for Atrial Fibrillation Management
Cai, M., & Heijman, J. (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000155 · Cited by 7
Cardiotoxicity and cardiac arrhythmias in cancer therapy: a review of current evidence
Kolomyitseva, V. A., Zaripova, L. A., Bazhina, D. A., Aidemirova, A. P., Gumerov, M. S., Uyanaeva, M. A., Furs, P. N., Gadeeva, V. M., Salyakhov, T. A., Gazislamova, L. R., et al. (2025) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov677295 · Cited by 2
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure—Therapy or Futility?
Golan, Y. B.-B., & Lambiase, P. D. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0870 · Cited by 1
Liu, L., Cai, A., Huang, J., Gu, W., Guo, R., Zhang, J., Xuan, H., Chan, Y., Xu, A., Cheung, B. M. Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04408-0 · Cited by 2
“This discrepancy may stem from the lack of benefit associated with slower heart rates in AF compared to sinus rhythm [38], and a low heart rate in patients with AF may be an expression of an underlying conduction disorder, which may be associated with impaired outcome itself [39].”
Diretriz Brasileira de Fibrilação Atrial – 2025
Cintra, F. D., Pisani, C. F., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lópes, R. D., do Nascimento, T. A., Lorga-Filho, A. M., de Albuquerque, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 29
Aloraini, S. S., Alghamdi, K., Alqarawi, W., & Alanazi, N. (2025) · Cureus · doi:10.7759/cureus.100006 · Cited by 1
“…debate focused on rate control vs. rhythm control, and evidence from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) and RACE (Rate Control versus Electrical cardioversion) trials indicated that a rate control strategy with anticoagulation was non-inferior [3,9,10-12].”
Chimura, M., Jhund, P. S., Henderson, A. D., Claggett, B. L., Desai, A. S., Lay‐Flurrie, J., Scalise, A. V., Rohwedder, K., Lam, C. S. P., Senni, M., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag008 · Cited by 1
Optimal heart rate in patients with atrial fibrillation: insights from the COOL-AF registry
Krittayaphong, R., Phrommintikul, A., Komoltri, C., Yindeengam, A., & Lip, G. Y. H. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04243-4 · Cited by 1
Liao, J., Kuo, L., Li, G., Tsai, C.-T., Huang, Y.-S., Chao, T., & Hung, C. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.01.015 · Cited by 1
Shawki, M., Rodrigues, T., Tan, E. X. Z., Gautam, A., Mandrola, J. M., Andrade, J. G., Lim, H. S., Perrin, M. J., & Wynn, G. J. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.03.1885 · Cited by 1
The Brain–Atrial Fibrillation–Recent Rehabilitation Axis: A Modern Approach
Piotrowska, A., Salwa, K., Kaziród-Wolski, K., & Sielski, J. K. (2026) · Healthcare · doi:10.3390/healthcare14060765 · Cited by 1
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.017 · Cited by 2
Therapeutisches Management des nichtvalvulären Vorhofflimmerns: Update 2013
Bode, K., Sommer, P., Bollmann, A., & Hindricks, G. (2013) · Herz · doi:10.1007/s00059-013-3940-x · Cited by 1
Cardiovascular Problems in the Elderly
Rich, M. W. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4441-0_19 · Cited by 1
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.